LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $5.1M of Standard BioTools Inc.
Director and 10% owner
Bought$5,134,321
$1.07Price
4,820,959Shares
+33%Stake
What LAB did for a copier
- $1,000 copied at Wed, Mar 5 open, $1.15
- $983
- S&P 500, same days
- −8.6%
Measured over 30 trading days, to the Apr 16 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −9.4% against the S&P 500, and 7 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Feb 28. Filed Tue, Mar 4. Returns use the Mar 5 open and the Apr 16 close. Not investment advice.